Pilot Study of Anti-Th2 Immunotherapy for the Treatment of Breast Cancer-Related Upper Extremity Lymphedema

Recent studies suggest that Th2 cells play a key role in the pathology of secondary lymphedema by elaborating cytokines such as IL4 and IL13. The aim of this study was to test the efficacy of QBX258, a monoclonal IL4/IL13 neutralizing antibody, in women with breast cancer–related lymphedema (BCRL)....

詳細記述

書誌詳細

主要な著者:	Babak J. Mehrara, Hyeung Ju Park, Raghu P. Kataru, Jacqueline Bromberg, Michelle Coriddi, Jung Eun Baik, Jinyeon Shin, Claire Li, Michele R. Cavalli, Elizabeth M. Encarnacion, Meghan Lee, Kimberly J. Van Zee, Elyn Riedel, Joseph H. Dayan
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2021-09-01
シリーズ:	Biology
主題:	lymphedema immunotherapy skin Th2 inflammation breast cancer keratinocytes
オンライン･アクセス:	https://www.mdpi.com/2079-7737/10/9/934
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!